Breadth + Progress

Novel target with strong genetic links to several age-related diseases underpins a broad pipeline with lead CNS asset VNA-318 advancing through the clinic.

OldMan_700

Pipeline

Vandria Pipeline

Vandria Pipeline

VNA-318 Differentiation with Acute Plus Long-Term Effects

Pre-Clinical Evidence Supports a Dual-Mode Cognitive Improvement with VNA-318

Vandria Data Graphic1

Vandria Data Graphic2

Vandria Data Graphic3

VNA-318 First-in-Human Trial Delivers Key Foundation to Facilitate Future Drug Development

Trial Summary

Partnering

Find out more about partnering opportunities for VNA-318

Partnering

Find out more about partnering opportunities for VNA-318